2-(2-Amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid hydrobromide

Catalog No. :
ACXYEU174
CAS No. :
1194434-39-3
Molecular Formula :
C10H10BrCl2N3O2
Molecular Weight :
355.02

IUPAC Name:2-(2-amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid hydrobromide

2-(2-Amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid hydrobromide
IUPAC Name2-(2-amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid hydrobromide
MDL No.MFCD27977649
Molecular FormulaC10H10BrCl2N3O2
Molecular Weight355.02
SMILESO=C(O)CN1C(N)=NC2=C(C(Cl)=C(Cl)C=C2)C1.[H]Br
InChI KeyYVUNMMZTHKHYMZ-UHFFFAOYSA-N
Synonym2-AMino-5,6-dichloro-3(4H)-quinazoline Acetic Acid HydrobroMide (Anagrelide IMpurity B);2-Amino-5,6-dichloro-3(4H)-quinazoline Acetic Acid Hydrobromide;2-Amino-5,6-dichloro-3(4H)-quinazoline Acetic Acid Hydrobromide \n(Anagrelide Impurity B);(2-Amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid hydrobromide;Thiocoraline Impurity1
CAS No.1194434-39-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXYEU174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXYEU174 route product structure diagram
    ACXYEU1741194434-39-3
Inquiry

2. ACXYEU174 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXYEU174 route product structure diagram
    ACXYEU1741194434-39-3
Inquiry

Comments (0)